Stock listing
NASDAQ:CELU Celularity Inc. Stock
Home listing (NASDAQ) of Celularity Inc.
Follow Celularity Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CELU
$0.80 USD -0.05 (-5.8%)
Close on Oct 30, 2026
- Day range
- $0.80 – $0.869 USDOct 30, 2026
- Volume
- 181,847 sharesOct 30, 2026
- Market cap
- $25.96M USDAt the close on Oct 30, 2026 · price × 32.45M shares outstanding
- 52-week range
- $0.56 – $2.55 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $7.72M USDMedian day 108,664 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CELU · Home | $0.80 USD | -0.049 (-5.8%) | 181,847 | $0.82 | $0.869 | $0.80 | $0.849 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CELU · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.80 | -0.049 | -5.8% | $0.82 | $0.869 | $0.80 | 181,847 | |
| $0.849 | -0.091 | -9.7% | $0.98 | $0.98 | $0.834 | 496,839 | |
| $0.94 | +0.15 | +19.0% | $0.821 | $1.04 | $0.782 | 350,936 | |
| $0.79 | +0.04 | +5.4% | $0.80 | $0.868 | $0.78 | 219,290 | |
| $0.75 | -0.228 | -23.3% | $0.964 | $1.00 | $0.66 | 629,002 | |
| $0.978 | -0.072 | -6.9% | $1.06 | $1.142 | $0.911 | 145,347 | |
| $1.05 | +0.03 | +2.9% | $1.07 | $1.08 | $1.01 | 144,726 | |
| $1.02 | -0.24 | -19.0% | $1.31 | $1.31 | $1.02 | 204,708 | |
| $1.26 | +0.10 | +8.6% | $1.16 | $1.30 | $1.16 | 60,140 | |
| $1.16 | -0.09 | -7.2% | $1.29 | $1.29 | $1.121 | 87,785 | |
| $1.25 | -0.08 | -6.0% | $1.33 | $1.33 | $1.22 | 64,070 | |
| $1.33 | +0.02 | +1.5% | $1.28 | $1.35 | $1.27 | 30,651 | |
| $1.31 | -0.11 | -7.7% | $1.39 | $1.41 | $1.28 | 80,188 | |
| $1.42 | -0.05 | -3.4% | $1.45 | $1.55 | $1.40 | 50,371 | |
| $1.47 | -0.09 | -5.8% | $1.56 | $1.57 | $1.461 | 43,731 | |
| $1.56 | +0.10 | +6.8% | $1.46 | $1.57 | $1.451 | 53,197 | |
| $1.46 | -0.01 | -0.7% | $1.46 | $1.50 | $1.43 | 103,708 | |
| $1.47 | -0.11 | -7.0% | $1.53 | $1.57 | $1.47 | 68,941 | |
| $1.58 | -0.13 | -7.6% | $1.70 | $1.769 | $1.54 | 260,947 | |
| $1.71 | +0.11 | +6.9% | $1.60 | $1.80 | $1.57 | 282,127 | |
| $1.60 | +0.22 | +15.9% | $1.37 | $1.635 | $1.36 | 221,844 | |
| $1.38 | +0.03 | +2.2% | $1.34 | $1.38 | $1.302 | 142,148 | |
| $1.35 | -0.02 | -1.5% | $1.37 | $1.37 | $1.28 | 55,429 | |
| $1.37 | -0.03 | -2.1% | $1.38 | $1.40 | $1.334 | 39,646 | |
| $1.40 | +0.02 | +1.4% | $1.40 | $1.46 | $1.35 | 113,620 | |
| $1.38 | +0.06 | +4.5% | $1.33 | $1.41 | $1.32 | 166,069 | |
| $1.32 | +0.17 | +14.8% | $1.17 | $1.35 | $1.17 | 454,723 | |
| $1.15 | -0.03 | -2.5% | $1.17 | $1.18 | $1.13 | 77,117 | |
| $1.18 | -0.06 | -4.8% | $1.22 | $1.26 | $1.16 | 154,730 | |
| $1.24 | -0.07 | -5.3% | $1.27 | $1.33 | $1.24 | 214,037 | |
| $1.31 | +0.04 | +3.1% | $1.28 | $1.35 | $1.22 | 188,400 | |
| $1.27 | -0.02 | -1.6% | $1.29 | $1.38 | $1.27 | 77,758 | |
| $1.29 | +0.05 | +4.0% | $1.26 | $1.389 | $1.21 | 181,095 | |
| $1.24 | -0.16 | -11.4% | $1.33 | $1.40 | $1.24 | 149,414 | |
| $1.40 | -0.01 | -0.7% | $1.32 | $1.43 | $1.31 | 206,968 | |
| $1.41 | -0.025 | -1.7% | $1.45 | $1.45 | $1.351 | 97,105 | |
| $1.435 | -0.005 | -0.3% | $1.405 | $1.48 | $1.385 | 158,545 | |
| $1.44 | -0.10 | -6.5% | $1.55 | $1.55 | $1.43 | 148,745 | |
| $1.54 | -0.14 | -8.3% | $1.70 | $1.734 | $1.52 | 249,671 | |
| $1.68 | -0.15 | -8.2% | $1.83 | $1.83 | $1.618 | 351,362 | |
| $1.83 | -0.03 | -1.6% | $1.85 | $1.894 | $1.78 | 363,695 | |
| $1.86 | -0.02 | -1.1% | $1.88 | $1.96 | $1.69 | 654,741 | |
| $1.88 | +0.03 | +1.6% | $1.86 | $2.07 | $1.71 | 1,622,079 | |
| $1.85 | +0.27 | +17.1% | $1.42 | $1.964 | $1.38 | 3,422,193 | |
| $1.58 | -0.52 | -24.8% | $2.145 | $2.20 | $1.48 | 15,087,260 | |
| $2.10 | +1.22 | +138.5% | $1.11 | $2.55 | $0.926 | 221,052,891 | |
| $0.88 | +0.08 | +9.9% | $0.806 | $0.976 | $0.78 | 177,414 | |
| $0.801 | +0.026 | +3.4% | $0.751 | $1.11 | $0.751 | 1,184,841 | |
| $0.775 | -0.025 | -3.2% | $0.775 | $0.86 | $0.749 | 37,347 | |
| $0.80 | +0.033 | +4.3% | $0.77 | $0.85 | $0.731 | 26,346 | |
| $0.767 | -0.011 | -1.4% | $0.701 | $0.82 | $0.701 | 46,739 | |
| $0.778 | +0.041 | +5.6% | $0.81 | $0.85 | $0.75 | 48,778 | |
| $0.737 | +0.041 | +5.8% | $0.709 | $0.80 | $0.709 | 72,811 | |
| $0.696 | +0.00 | 0.0% | $0.68 | $0.739 | $0.68 | 17,585 | |
| $0.696 | +0.00 | +0.1% | $0.704 | $0.72 | $0.69 | 11,415 | |
| $0.695 | +0.005 | +0.8% | $0.714 | $0.714 | $0.69 | 7,070 | |
| $0.69 | -0.01 | -1.5% | $0.70 | $0.712 | $0.686 | 16,419 | |
| $0.70 | +0.014 | +2.0% | $0.708 | $0.73 | $0.686 | 30,129 | |
| $0.687 | -0.014 | -2.0% | $0.68 | $0.735 | $0.68 | 25,668 | |
| $0.701 | +0.018 | +2.6% | $0.69 | $0.733 | $0.69 | 18,067 | |
| $0.683 | -0.051 | -7.0% | $0.74 | $0.74 | $0.683 | 25,838 | |
| $0.734 | +0.031 | +4.4% | $0.693 | $0.75 | $0.693 | 10,292 | |
| $0.703 | +0.043 | +6.5% | $0.66 | $0.782 | $0.66 | 77,815 | |
| $0.66 | +0.025 | +3.9% | $0.64 | $0.67 | $0.64 | 34,469 | |
| $0.635 | -0.045 | -6.6% | $0.715 | $0.72 | $0.601 | 80,001 | |
| $0.68 | +0.01 | +1.5% | $0.68 | $0.72 | $0.68 | 18,080 |
- Ticker
- NASDAQ:CELU
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Latest news
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Oct 29, 2026
Closed $0.849 (-9.7%) on Oct 29, 2026
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Oct 22, 2026
Closed $1.05 (+2.9%) on Oct 22, 2026
Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Oct 20, 2026
Closed $1.02 (-19.0%) on Oct 21, 2026
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
Sep 30, 2026
Closed $1.35 (-1.5%) on Sep 30, 2026
Celularity Announces Naveen Jain to Join Board of Directors
Sep 29, 2026
Closed $1.37 (-2.1%) on Sep 29, 2026
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Sep 24, 2026
Closed $1.32 (+14.8%) on Sep 24, 2026
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform
Aug 27, 2026
Closed $2.10 (+138.5%) on Aug 27, 2026
Celularity Provides Update Regarding Nasdaq Listing Compliance
Aug 25, 2026
Closed $0.88 (+9.9%) on Aug 26, 2026
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
Jun 4, 2026
Closed $0.995 (-2.5%) on Jun 4, 2026
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
Jun 3, 2026
Closed $1.02 (-3.8%) on Jun 3, 2026
Financings
Private placement of senior secured convertible notes and warrants
Sep 24, 2026
Tranche closed: US$10M raised · Warrants at US$1.5 for 60 months · Odeon Capital Group LLC
Dealers: Odeon Capital Group LLC (lead)
Buyers: Philip A. Barach
Use of proceeds: Support commercial execution and manufacturing expansion
Decks
Investor Presentation (February 2025)
Investor deck · 28 slides · February 2025
Investor Presentation (September 2024)
Investor deck · 22 slides · September 2024
Investor Day (May 2024)
Investor day · 59 slides · May 21, 2024
Investor Presentation (June 2023)
Investor deck · 14 slides · June 2023
Celularity Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 121 in all · newest Oct 29, 2026 · oldest 2021
- Decks
- 14 decks · latest February 2025
Where Celularity Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CELU · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CELU | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Celularity Inc.